Leynek Medical Unveils ReneCare Device: All-in-One Remote Monitoring for Chronic Care in Oncology and Cardiology
- Leynek Medical, Inc.
- May 23
- 2 min read
[Ottawa, CANADA, May 23, 2025] – Leynek Medical Inc. is excited to announce the design release of the ReneCare Device, an industrial designed, multi-functional tool set to redefine remote patient monitoring in oncology and cardiology. This all-in-one device integrates a digital stethoscope, pulse oximeter, skin temperature sensor, and two-lead ECG—enabling clinicians to collect rich clinical data from a single, portable platform.
As remote care payment models continue to evolve, especially for patients with chronic conditions, the ReneCare Device offers a breakthrough in at-home diagnostics and virtual care. With rising demand for reliable remote tools, the ReneCare Device is being hailed by early testers and health systems as a powerful enabler for continuous monitoring, early intervention, and more personalized care pathways.
"Our goal was to create a tool that makes it easier for clinics, hospitals, and home care providers to manage these remote devices and stay connected to their patients without compromising on clinical data quality," said William Jones, CEO and Co-Founder of Leynek Medical. "This device is designed for those aged 65+ and consolidates multiple clinical-grade tools into one compact system—making it simpler for clinics, hospitals, and pharmacies to manage the logistics."
Key Features:
Digital Stethoscope – High-fidelity auscultation for heart and lung sounds
Pulse Oximeter – Real-time oxygen saturation and heart rate monitoring
Skin Temperature Sensor – Accurate readings for infection and symptom tracking
ECG – Reliable cardiac rhythm assessment
One location - Designed to be familiar to a 65+ aged person and used in one location for all sensors
The ReneCare Device will be compatible with the existing ReneCare platform, allowing providers to receive patient-generated data in real-time, integrate it into clinical workflows, and intervene earlier when necessary. This is especially impactful for oncology and cardiology patients, who often require frequent symptom monitoring and prompt clinical action.
The unveiling of the ReneCare Device design has already generated buzz among remote care leaders and chronic disease specialists. As Leynek prepares for pilot programs and clinical validation, the company is actively engaging partners to explore deployment opportunities.
The ReneCare Device is in the design and validation phase and has not yet been cleared or approved by regulatory authorities in all markets. The ReneCare Device is for investigational use only.
To learn more or to inquire about collaboration, visit www.leynekmedical.com or contact info@leynekmedical.com.
About Leynek Medical
Leynek Medical is a digital health and medical device company focused on solving critical gaps in cancer and chronic care management. Through intelligent software platforms and innovative hardware, Leynek empowers providers and patients to stay better connected throughout the care journey.
Media Contact:
Kommentarer